查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1957639

2026年全球藥品單劑量包裝市場報告

Pharmaceutical Unit-Dose Packaging Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，單劑量藥品包裝市場發展迅速。預計該市場將從2025年的545億美元成長到2026年的607.9億美元，年複合成長率達11.6%。過去幾年的成長主要歸功於醫院加強藥物安全措施、對精準用藥需求增加、注射和生物製藥製劑的推廣應用、門診服務的成長以及藥品包裝材料的進步。

預計未來幾年，單劑量藥品包裝市場將快速成長，到2030年將達到930.7億美元，複合年成長率（CAGR）為11.2%。預測期內的成長預計將受到以下因素的推動：智慧包裝技術的廣泛應用、對以患者為中心的給藥方式的日益重視、生物製藥和特種藥品的擴張、對合規包裝需求的增加以及藥品包裝生產線自動化水平的提高。預測期內的關鍵趨勢包括：安全單劑量包裝的廣泛應用、對泡殼和預填充式注射器形式的需求增加、追蹤技術的廣泛應用、高阻隔包裝材料的普及以及對減少藥物濫用的日益重視。

預計未來幾年，免疫接種計劃和疫苗宣傳活動的擴大將推動單劑量藥品包裝市場的成長。免疫接種計劃和疫苗宣傳活動是旨在透過系統性地接種疫苗來保護民眾免受感染疾病的公共衛生措施。這些計畫和宣傳活動的擴大是由於感染疾病率的上升，促使各國政府和衛生組織加強感染預防措施，並保護公眾健康。單劑量藥品包裝透過確保劑量準確、最大限度地減少藥物濫用、保持無菌以及便於大規模疫苗接種活動中的分發和接種，為免疫接種計劃和疫苗接種宣傳活動提供支持。例如，根據英國政府機構英國衛生安全局的數據，截至2023年6月，在2022-2023學年，共有3,502,566名從學前班到九年級的兒童和學生在學齡免疫接種計劃中接種了疫苗。相較之下，2021-2022學年同年齡層的兒童人數為3,615,536人。因此，免疫接種計劃和疫苗接種宣傳活動的擴大正在推動單劑量藥品包裝市場的成長。

在藥品單劑量包裝市場中，主要企業正致力於開發先進的解決方案，例如無菌單劑量學名藥，以提高給藥的準確性並簡化醫院和藥房的操作流程。無菌單劑量學名藥是預先計量並獨立包裝的藥物，可確保安全、準確地給藥，避免微生物污染，是品牌無菌藥物的一種經濟有效的替代方案。例如，2023年8月，美國製藥公司Ritedose Pharmaceuticals宣布推出色甘酸鈉吸入溶液USP（20毫克/2毫升）。這種新型無菌單劑量學名藥是一種吸入式抗發炎藥，用於預防和控制氣喘，每盒包含60支單劑量管瓶。這擴展了Ritedose的吸入溶液產品線，並確保為需要定期使用藥物的客戶提供穩定的供應。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球藥品單劑量包裝市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 永續性、氣候技術、循環經濟
    • 工業4.0和智慧製造
    • 數位化、雲端運算、巨量資料、網路安全
    • 物聯網、智慧基礎設施、互聯生態系統
    • 人工智慧（AI）和自主人工智慧
  • 主要趨勢
    • 單劑量安全包裝的推廣
    • 對泡殼包裝和預填充式注射器形式的需求增加。
    • 追蹤溯源技術整合的進展
    • 高阻隔包裝材料的擴展
    • 人們越來越關注減少藥物濫用問題

第5章 終端用戶產業市場分析

  • 醫院
  • 藥局
  • 製藥公司
  • 居家醫療服務提供者
  • 合約包裝組織

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球藥品單劑量包裝市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球藥品單劑量包裝市場規模、對比及成長率分析
  • 全球藥品單劑量包裝市場表現：規模與成長，2020-2025年
  • 全球藥品單劑量包裝市場預測：規模與成長，2025-2030年，2035年預測

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 依產品
  • 泡殼包裝、安瓿瓶、管瓶、預填充式注射器和藥筒
  • 材料
  • 塑膠、玻璃、紙張和紙板、金屬
  • 按最終用途
  • 眼科用藥、注射、生物製藥、創傷護理、呼吸系統治療、口服藥物
  • 依類型細分：泡殼包裝
  • 推壓式泡殼、剝離式泡殼、冷成型泡殼、熱成型泡殼
  • 按類型細分：安瓿瓶
  • 開口安瓿、閉口安瓿、火焰密封安瓿、壓力密封安瓿
  • 按類型細分：管瓶
  • 單劑量管瓶、多劑量管瓶、壓蓋頸管瓶、螺旋頸管瓶
  • 按類型細分：預填充式注射器和藥筒
  • 一次性預填充式注射器、可重複使用預填充式注射器、玻璃藥筒、塑膠藥筒

第10章 區域與國別分析

  • 全球藥品單劑量包裝市場：依地區分類，歷史資料及預測（2020-2025年、2025-2030年預測、2035年預測）
  • 全球藥品單劑量包裝市場：依國家分類，實際值及預測值，2020-2025年、2025-2030年預測值、2035年預測值

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 藥品單劑量包裝市場：競爭格局及市場佔有率（2024年）
  • 藥品單劑量包裝市場：公司估值矩陣
  • 藥品單劑量包裝市場：公司概況
    • Pfizer Inc.
    • Johnson & Johnson Innovation LLC
    • Merck & Co. Inc.
    • AbbVie Inc.
    • Becton Dickinson and Company

第37章 其他大型企業和創新企業

  • Amcor Plc, Nipro Corporation, Aptar Group Inc., West Pharmaceutical Services Inc., Constantia Flexibles Group GmbH, Klockner Pentaplast, Stevanato Group SpA, SGD SA, SP Group, Jones Healthcare Group, Innovative Pharmacy Packaging Corporation Inc., Medical Packaging Inc. LLC, Adelphi Healthcare Packaging, Sonic Packaging Industries, Alfipa

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年藥品單劑量包裝市場：提供新機會的國家
  • 2030年藥品單劑量包裝市場：充滿新機會的細分市場
  • 2030年藥品單劑量包裝市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第41章附錄

簡介目錄
Product Code: PH6MPUDP01_G26Q1

Pharmaceutical unit-dose packaging involves packaging medication in individual, pre-measured containers. Its primary purpose is to provide accurate dosing, reduce medication errors, and improve patient safety. It also helps preserve drug stability, extend shelf life, and enables easy handling and administration in hospitals, pharmacies, and home care settings.

The primary product types in pharmaceutical unit-dose packaging include blisters, ampoules, vials, and prefilled syringes and cartridges. Blisters in pharmaceutical unit-dose packaging are sealed compartments made of plastic or aluminum that individually enclose a single tablet or capsule, providing product protection, precise dosing, and tamper evidence. They are manufactured from various materials such as plastics, glass, paper and paperboard, and metal, and are used for multiple applications, including ophthalmic, injectable, biologics, wound care, respiratory therapy, and oral.

Tariffs are impacting the pharmaceutical unit-dose packaging market by increasing costs of imported plastics, specialty glass, aluminum foils, and packaging machinery used across blisters, vials, ampoules, and prefilled syringes. North America and Europe are most affected due to reliance on imported raw materials and equipment, while Asia-Pacific faces pricing pressure on packaging exports. These tariffs are raising production costs and affecting packaging margins. However, they are also driving local material sourcing, regional packaging manufacturing expansion, and innovation in cost-efficient and sustainable unit-dose packaging solutions.

The pharmaceutical unit-dose packaging market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical unit-dose packaging market statistics, including pharmaceutical unit-dose packaging industry global market size, regional shares, competitors with a pharmaceutical unit-dose packaging market share, detailed pharmaceutical unit-dose packaging market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical unit-dose packaging industry. This pharmaceutical unit-dose packaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmaceutical unit-dose packaging market size has grown rapidly in recent years. It will grow from $54.5 billion in 2025 to $60.79 billion in 2026 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to increasing hospital medication safety initiatives, rising demand for precise drug dosing, expansion of injectable and biologic therapies, growth of outpatient care settings, advancements in pharmaceutical packaging materials.

The pharmaceutical unit-dose packaging market size is expected to see rapid growth in the next few years. It will grow to $93.07 billion in 2030 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to increasing adoption of smart packaging technologies, rising focus on patient-centric drug delivery, expansion of biologics and specialty drugs, growing demand for compliance-ready packaging, increasing automation in pharmaceutical packaging lines. Major trends in the forecast period include increasing adoption of unit-dose safety packaging, rising demand for blister and prefilled syringe formats, growing integration of track-and-trace technologies, expansion of high-barrier packaging materials, enhanced focus on medication error reduction.

The expansion of immunization programs and vaccination campaigns is anticipated to drive the growth of the pharmaceutical unit-dose packaging market in the coming years. Immunization programs and vaccination campaigns are organized public health efforts aimed at protecting populations from infectious diseases through the systematic administration of vaccines. The growth in these programs and campaigns is fueled by the increasing occurrence of infectious disease outbreaks, prompting governments and health organizations to enhance measures to prevent transmission and safeguard public health. Pharmaceutical unit-dose packaging supports immunization programs and vaccination campaigns by ensuring precise dosing, minimizing medication errors, maintaining sterility, and facilitating distribution and administration in large-scale vaccination initiatives. For example, in June 2023, according to the UK Health Security Agency, a UK government agency, the school-aged vaccination program recorded a total of 3,502,566 children (from Reception to Year 9) vaccinated in 2022-2023, compared to 3,615,536 children in the same age group during 2021-2022. Thus, the expansion of immunization programs and vaccination campaigns is driving the growth of the pharmaceutical unit-dose packaging market.

Major companies operating in the pharmaceutical unit-dose packaging market are concentrating on creating advanced solutions such as sterile unit-dose generic products to enhance dosing accuracy and optimize hospital and pharmacy workflows. Sterile unit-dose generic products consist of pre-measured, individually packaged medications designed to be free from microbial contamination, ensuring safe and precise dosing while providing a cost-effective alternative to branded sterile drugs. For example, in August 2023, Ritedose Pharmaceuticals, a US-based pharmaceutical company, introduced a cromolyn sodium inhalation solution, USP (20 mg/2 ml). This new sterile unit-dose generic product serves as an inhaled anti-inflammatory agent for the preventive management of asthma and is provided in cartons containing 60 single-dose vials. It broadens Ritedose's range of inhalation solutions and ensures a dependable supply for clients requiring this medication regularly.

In November 2024, Safecor Health, a US-based unit-dose repackaging company, acquired the US unit-dose packaging business from Viatris Inc. for an undisclosed sum. Through this acquisition, Safecor Health intends to broaden its generic unit-dose product portfolio, improve cost efficiency, and reinforce its supply chain partnerships to deliver more comprehensive solutions to healthcare providers and manufacturers. Viatris Inc. is a US-based pharmaceutical company that provides pharmaceutical unit-dose packaging.

Major companies operating in the pharmaceutical unit-dose packaging market are Pfizer Inc., Johnson & Johnson Innovation LLC, Merck & Co. Inc., AbbVie Inc., Becton Dickinson and Company, Amcor Plc, Nipro Corporation, Aptar Group Inc., West Pharmaceutical Services Inc., Constantia Flexibles Group GmbH, Klockner Pentaplast, Stevanato Group S.p.A., SGD SA, SP Group, Jones Healthcare Group, Innovative Pharmacy Packaging Corporation Inc., Medical Packaging Inc. LLC, Adelphi Healthcare Packaging, Sonic Packaging Industries, Alfipa, Unit Pack Company Inc.

North America was the largest region in the pharmaceutical unit-dose packaging market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical unit-dose packaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmaceutical unit-dose packaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical unit-dose packaging market consists of sales of products such as unit-dose pouches, sachets, strip packs, stick packs, prefilled droppers, nasal spray units, and ophthalmic single-dose containers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Unit-Dose Packaging Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses pharmaceutical unit-dose packaging market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical unit-dose packaging ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharmaceutical unit-dose packaging market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Blisters; Ampoules; Vials; Prefilled Syringes And Cartridges
  • 2) By Material: Plastics; Glass; Paper And Paperboard; Metal
  • 3) By End-Use: Ophthalmic; Injectable; Biologics; Wound Care; Respiratory Therapy; Orals
  • Subsegments:
  • 1) By Blisters: Push-Through Blisters; Peelable Blisters; Cold Formed Blisters; Thermoformed Blisters
  • 2) By Ampoules: Open Ampoules; Closed Ampoules; Flame-Sealed Ampoules; Pressure-Sealed Ampoules
  • 3) By Vials: Single-Dose Vials; Multi-Dose Vials; Crimp Neck Vials; Screw Neck Vials
  • 4) By Prefilled Syringes And Cartridges: Disposable Prefilled Syringes; Reusable Prefilled Syringes; Glass Cartridges; Plastic Cartridges
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson Innovation LLC; Merck & Co. Inc.; AbbVie Inc.; Becton Dickinson and Company; Amcor Plc; Nipro Corporation; Aptar Group Inc.; West Pharmaceutical Services Inc.; Constantia Flexibles Group GmbH; Klockner Pentaplast; Stevanato Group S.p.A.; SGD SA; SP Group; Jones Healthcare Group; Innovative Pharmacy Packaging Corporation Inc.; Medical Packaging Inc. LLC; Adelphi Healthcare Packaging; Sonic Packaging Industries; Alfipa; Unit Pack Company Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Pharmaceutical Unit-Dose Packaging Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Pharmaceutical Unit-Dose Packaging Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Pharmaceutical Unit-Dose Packaging Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Pharmaceutical Unit-Dose Packaging Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Sustainability, Climate Tech & Circular Economy
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Unit-Dose Safety Packaging
    • 4.2.2 Rising Demand For Blister And Prefilled Syringe Formats
    • 4.2.3 Growing Integration Of Track-And-Trace Technologies
    • 4.2.4 Expansion Of High-Barrier Packaging Materials
    • 4.2.5 Enhanced Focus On Medication Error Reduction

5. Pharmaceutical Unit-Dose Packaging Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Pharmacies
  • 5.3 Pharmaceutical Manufacturers
  • 5.4 Home Healthcare Providers
  • 5.5 Contract Packaging Organizations

6. Pharmaceutical Unit-Dose Packaging Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pharmaceutical Unit-Dose Packaging Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Pharmaceutical Unit-Dose Packaging PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Pharmaceutical Unit-Dose Packaging Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Pharmaceutical Unit-Dose Packaging Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Pharmaceutical Unit-Dose Packaging Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pharmaceutical Unit-Dose Packaging Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pharmaceutical Unit-Dose Packaging Market Segmentation

  • 9.1. Global Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blisters, Ampoules, Vials, Prefilled Syringes And Cartridges
  • 9.2. Global Pharmaceutical Unit-Dose Packaging Market, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Plastics, Glass, Paper And Paperboard, Metal
  • 9.3. Global Pharmaceutical Unit-Dose Packaging Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Ophthalmic, Injectable, Biologics, Wound Care, Respiratory Therapy, Orals
  • 9.4. Global Pharmaceutical Unit-Dose Packaging Market, Sub-Segmentation Of Blisters, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Push-Through Blisters, Peelable Blisters, Cold Formed Blisters, Thermoformed Blisters
  • 9.5. Global Pharmaceutical Unit-Dose Packaging Market, Sub-Segmentation Of Ampoules, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Open Ampoules, Closed Ampoules, Flame-Sealed Ampoules, Pressure-Sealed Ampoules
  • 9.6. Global Pharmaceutical Unit-Dose Packaging Market, Sub-Segmentation Of Vials, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-Dose Vials, Multi-Dose Vials, Crimp Neck Vials, Screw Neck Vials
  • 9.7. Global Pharmaceutical Unit-Dose Packaging Market, Sub-Segmentation Of Prefilled Syringes And Cartridges, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Disposable Prefilled Syringes, Reusable Prefilled Syringes, Glass Cartridges, Plastic Cartridges

10. Pharmaceutical Unit-Dose Packaging Market Regional And Country Analysis

  • 10.1. Global Pharmaceutical Unit-Dose Packaging Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Pharmaceutical Unit-Dose Packaging Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pharmaceutical Unit-Dose Packaging Market

  • 11.1. Asia-Pacific Pharmaceutical Unit-Dose Packaging Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pharmaceutical Unit-Dose Packaging Market

  • 12.1. China Pharmaceutical Unit-Dose Packaging Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pharmaceutical Unit-Dose Packaging Market

  • 13.1. India Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pharmaceutical Unit-Dose Packaging Market

  • 14.1. Japan Pharmaceutical Unit-Dose Packaging Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pharmaceutical Unit-Dose Packaging Market

  • 15.1. Australia Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pharmaceutical Unit-Dose Packaging Market

  • 16.1. Indonesia Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pharmaceutical Unit-Dose Packaging Market

  • 17.1. South Korea Pharmaceutical Unit-Dose Packaging Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pharmaceutical Unit-Dose Packaging Market

  • 18.1. Taiwan Pharmaceutical Unit-Dose Packaging Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pharmaceutical Unit-Dose Packaging Market

  • 19.1. South East Asia Pharmaceutical Unit-Dose Packaging Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pharmaceutical Unit-Dose Packaging Market

  • 20.1. Western Europe Pharmaceutical Unit-Dose Packaging Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pharmaceutical Unit-Dose Packaging Market

  • 21.1. UK Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pharmaceutical Unit-Dose Packaging Market

  • 22.1. Germany Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pharmaceutical Unit-Dose Packaging Market

  • 23.1. France Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pharmaceutical Unit-Dose Packaging Market

  • 24.1. Italy Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pharmaceutical Unit-Dose Packaging Market

  • 25.1. Spain Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pharmaceutical Unit-Dose Packaging Market

  • 26.1. Eastern Europe Pharmaceutical Unit-Dose Packaging Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pharmaceutical Unit-Dose Packaging Market

  • 27.1. Russia Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pharmaceutical Unit-Dose Packaging Market

  • 28.1. North America Pharmaceutical Unit-Dose Packaging Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pharmaceutical Unit-Dose Packaging Market

  • 29.1. USA Pharmaceutical Unit-Dose Packaging Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pharmaceutical Unit-Dose Packaging Market

  • 30.1. Canada Pharmaceutical Unit-Dose Packaging Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pharmaceutical Unit-Dose Packaging Market

  • 31.1. South America Pharmaceutical Unit-Dose Packaging Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pharmaceutical Unit-Dose Packaging Market

  • 32.1. Brazil Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pharmaceutical Unit-Dose Packaging Market

  • 33.1. Middle East Pharmaceutical Unit-Dose Packaging Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pharmaceutical Unit-Dose Packaging Market

  • 34.1. Africa Pharmaceutical Unit-Dose Packaging Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pharmaceutical Unit-Dose Packaging Market Regulatory and Investment Landscape

36. Pharmaceutical Unit-Dose Packaging Market Competitive Landscape And Company Profiles

  • 36.1. Pharmaceutical Unit-Dose Packaging Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Pharmaceutical Unit-Dose Packaging Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Pharmaceutical Unit-Dose Packaging Market Company Profiles
    • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Johnson & Johnson Innovation LLC Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

37. Pharmaceutical Unit-Dose Packaging Market Other Major And Innovative Companies

  • Amcor Plc, Nipro Corporation, Aptar Group Inc., West Pharmaceutical Services Inc., Constantia Flexibles Group GmbH, Klockner Pentaplast, Stevanato Group S.p.A., SGD SA, SP Group, Jones Healthcare Group, Innovative Pharmacy Packaging Corporation Inc., Medical Packaging Inc. LLC, Adelphi Healthcare Packaging, Sonic Packaging Industries, Alfipa

38. Global Pharmaceutical Unit-Dose Packaging Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pharmaceutical Unit-Dose Packaging Market

40. Pharmaceutical Unit-Dose Packaging Market High Potential Countries, Segments and Strategies

  • 40.1 Pharmaceutical Unit-Dose Packaging Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Pharmaceutical Unit-Dose Packaging Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Pharmaceutical Unit-Dose Packaging Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer